Nodular thyroid disease laboratory findings

Nodular thyroid disease Microchapters
Home
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Nodular thyroid disease from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Ultrasound
Fine Needle Aspiration
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Nodular thyroid disease laboratory findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Nodular thyroid disease laboratory findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Nodular thyroid disease laboratory findings
CDC on Nodular thyroid disease laboratory findings
Nodular thyroid disease laboratory findings in the news
Blogs on Nodular thyroid disease laboratory findings
Directions to Hospitals Treating Nodular thyroid disease
Risk calculators and risk factors for Nodular thyroid disease laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Laboratory Findings

• The thyroid stimulating hormone (TSH) is the most important test, as it can identify patients with unsuspected thyrotoxicosis. The next step would likely be a scan. Serum calcitonin should be measured when medullary carcinoma is suspected, however this is controversial and expensive.